Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 25, 2022

SELL
$463.67 - $597.16 $554,549 - $714,203
-1,196 Closed
0 $0
Q1 2022

May 10, 2022

SELL
$524.57 - $735.42 $15,737 - $22,062
-30 Reduced 2.45%
1,196 $674,000
Q4 2021

Jan 27, 2022

BUY
$708.84 - $794.68 $111,996 - $125,559
158 Added 14.79%
1,226 $926,000
Q3 2021

Oct 28, 2021

BUY
$657.71 - $825.77 $48,670 - $61,106
74 Added 7.44%
1,068 $797,000
Q2 2021

Jul 14, 2021

BUY
$576.64 - $649.04 $573,180 - $645,145
994 New
994 $640,000

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.38B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Marshall Financial Group LLC Portfolio

Follow Marshall Financial Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Financial Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Financial Group LLC with notifications on news.